Skip to menu Skip to content Skip to footer

2018

Other Outputs

Breast cancer: molecular pathology driving precision oncology

McCart Reed, Amy and Lakhani, Sunil (2018). Breast cancer: molecular pathology driving precision oncology. MJA Insight website: Medical Journal of Australia.

Breast cancer: molecular pathology driving precision oncology

2018

Journal Article

CEP55 is a determinant of cell fate during perturbed mitosis in breast cancer

Kalimutho, Murugan, Sinha, Debottam, Jeffery, Jessie, Nones, Katia, Srihari, Sriganesh, Fernando, Winnie C., Duijf, Pascal H. G., Vennin, Claire, Raninga, Prahlad, Nanayakkara, Devathri, Mittal, Deepak, Saunus, Jodi M., Lakhani, Sunil R., López, J Alejandro, Spring, Kevin J., Timpson, Paul, Gabrielli, Brian, Waddell, Nicola and Khanna, Kum Kum (2018). CEP55 is a determinant of cell fate during perturbed mitosis in breast cancer. EMBO Molecular Medicine, 10 (9) e8566. doi: 10.15252/emmm.201708566

CEP55 is a determinant of cell fate during perturbed mitosis in breast cancer

2018

Journal Article

Invasion in breast lesions: the role of the epithelial-stroma barrier

Rakha, Emad A., Miligy, Islam M., Gorringe, Kylie L., Toss, Michael S., Green, Andrew R., Fox, Stephen B., Schmitt, Fernando C., Tan, Puay-Hoon, Tse, Gary M., Badve, Sunil, Decker, Thomas, Vincent-Salomon, Anne, Dabbs, David J., Foschini, Maria P., Moreno, Filipa, Wentao, Yang, Geyer, Felipe C., Reis-Filho, Jorge S., Pinder, Sarah E., Lakhani, Sunil R. and Ellis, Ian O. (2018). Invasion in breast lesions: the role of the epithelial-stroma barrier. Histopathology, 72 (7), 1075-1083. doi: 10.1111/his.13446

Invasion in breast lesions: the role of the epithelial-stroma barrier

2018

Journal Article

Mixed ductal-lobular carcinomas: evidence for progression from ductal to lobular morphology

McCart Reed, Amy E., Kutasovic, Jamie R., Nones, Katia, Saunus, Jodi M., Da Silva, Leonard, Newell, Felicity, Kazakoff, Stephen, Melville, Lewis, Jayanthan, Janani, Vargas, Ana Cristina, Reid, Lynne E., Beesley, Jonathan, Chen, Xiao Qing, Patch, Anne Marie, David Clouston, D., Porter, Alan, Evans, Elizabeth, Pearson, John V., Chenevix-Trench, Georgia, Cummings, Margaret C., Waddell, Nic, Lakhani, Sunil R. and Simpson, Peter T. (2018). Mixed ductal-lobular carcinomas: evidence for progression from ductal to lobular morphology. The Journal of Pathology, 244 (4), 460-468. doi: 10.1002/path.5040

Mixed ductal-lobular carcinomas: evidence for progression from ductal to lobular morphology

2018

Journal Article

Characterization of a novel breast cancer cell line derived from a metastatic bone lesion of a breast cancer patient

Johnson, Julie, Bessette, Darrell C., Saunus, Jodi M., Smart, Chanel E., Song, Sarah, Johnston, Rebecca L., Cocciardi, Sibylle, Rozali, Esdy N., Johnstone, Cameron N., Vargas, Ana Christina, Kazakoff, Stephen H., BioBank, Victorian Cancer, Khanna, Kum Kum, Lakhani, Sunil R., Chenevix-Trench, Georgia, Simpson, Peter T., Nones, Katia, Waddell, Nicola and Al-Ejeh, Fares (2018). Characterization of a novel breast cancer cell line derived from a metastatic bone lesion of a breast cancer patient. Breast Cancer Research and Treatment, 170 (1), 179-188. doi: 10.1007/s10549-018-4719-9

Characterization of a novel breast cancer cell line derived from a metastatic bone lesion of a breast cancer patient

2018

Journal Article

Expression of MAGE-A and NY-ESO-1 cancer-testis antigens is enriched in triple-negative invasive breast cancers

Raghavendra, Ashwini, Kalita-de Croft, Priyakshi, Vargas, Ana Cristina, Smart, Chanel E., Simpson, Peter T., Saunus, Jodi M. and Lakhani, Sunil R. (2018). Expression of MAGE-A and NY-ESO-1 cancer-testis antigens is enriched in triple-negative invasive breast cancers. Histopathology, 73 (1), 68-80. doi: 10.1111/his.13498

Expression of MAGE-A and NY-ESO-1 cancer-testis antigens is enriched in triple-negative invasive breast cancers

2018

Journal Article

Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study

Copson, Ellen R, Maishman, Tom C, Tapper, Will J, Cutress, Ramsey I, Greville-Heygate, Stephanie, Altman, Douglas G, Eccles, Bryony, Gerty, Sue, Durcan, Lorraine T, Jones, Louise, Evans, D Gareth, Thompson, Alastair M, Pharoah, Paul, Easton, Douglas F, Dunning, Alison M, Hanby, Andrew, Lakhani, Sunil, Eeles, Ros, Gilbert, Fiona J, Hamed, Hisham, Hodgson, Shirley, Simmonds, Peter, Stanton, Louise and Eccles, Diana M (2018). Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study. The Lancet. Oncology, 19 (2), 169-180. doi: 10.1016/S1470-2045(17)30891-4

Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study

2018

Journal Article

The Brisbane Breast Bank

McCart Reed, Amy E., Saunus, Jodi M., Ferguson, Kaltin, Niland, Colleen, Simpson, Peter T. and Lakhani, Sunil R. (2018). The Brisbane Breast Bank. Open Journal of Bioresources, 5 (5). doi: 10.5334/ojb.33

The Brisbane Breast Bank

2018

Conference Publication

Expression of ARGLU and FBXL3 is highly prognostic for invasive lobular carcinoma

Coorey, Craig, Lal, Samir, Kutasovic, Jamie, Niland, Colleen, Ferguson, Kaltin, Kuo, Lu Yu, Reid, Lynne, Evans, Elizabeth, Porter, Alan, Lakhani, Sunil, McCart Reed, Amy and Simpson, Peter (2018). Expression of ARGLU and FBXL3 is highly prognostic for invasive lobular carcinoma. Pathology Update 2018, Sydney, NSW Australia, 2-4 March 2018. London, United Kingdom: Lippincott Williams & Wilkins. doi: 10.1016/j.pathol.2017.12.166

Expression of ARGLU and FBXL3 is highly prognostic for invasive lobular carcinoma

2018

Conference Publication

Proteomic analysis of the mouse brain stromal microenvironment: a milieu intérieur of metabolic reprogramming

Kalita de Croft, Priyakshi , Straube, Jasmin , Al-Ejeh, Fares , M Saunus,Jodi and R Lakhani, Sunil (2018). Proteomic analysis of the mouse brain stromal microenvironment: a milieu intérieur of metabolic reprogramming. 30th Lorne Cancer Conference 2018, Lorne, Victoria, Australia, 8th-11th February, 2018.

Proteomic analysis of the mouse brain stromal microenvironment: a milieu intérieur of metabolic reprogramming

2018

Book Chapter

Breast cancer - pathology and genetics

McCart Reed, Amy Ellen, Kalaw, Emarene, Reid, Andrew Scott and Lakhani, Sunil R. (2018). Breast cancer - pathology and genetics. Encyclopedia of cancer. (pp. 170-183) edited by Paolo Boffetta and Pierre Hainaut. Cambridge, MA United States: Academic Press. doi: 10.1016/B978-0-12-801238-3.65263-7

Breast cancer - pathology and genetics

2017

Journal Article

Association analysis identifies 65 new breast cancer risk loci

Michailidou, Kyriaki, Lindström, Sara, Dennis, Joe, Beesley, Jonathan, Hui, Shirley, Kar, Siddhartha, Lemaçon, Audrey, Soucy, Penny, Glubb, Dylan, Rostamianfar, Asha, Bolla, Manjeet K, Wang, Qin, Tyrer, Jonathan, Dicks, Ed, Lee, Andrew, Wang, Zhaoming, Allen, Jamie, Keeman, Renske, Eilber, Ursula, French, Juliet D, Qing Chen, Xiao, Fachal, Laura, McCue, Karen, McCart Reed, Amy E, Ghoussaini, Maya, Carroll, Jason S, Jiang, Xia, Finucane, Hilary, Adams, Marcia ... Easton, Douglas F (2017). Association analysis identifies 65 new breast cancer risk loci. Nature, 551 (7678), 92-94. doi: 10.1038/nature24284

Association analysis identifies 65 new breast cancer risk loci

2017

Journal Article

Multidimensional phenotyping of breast cancer cell lines to guide preclinical research

Saunus, Jodi M., Smart, Chanel E., Kutasovic, Jamie R., Johnston, Rebecca L., Kalita-de Croft, Priyakshi, Miranda, Mariska, Rozali, Esdy N., Vargas, Ana Cristina, Reid, Lynne E., Lorsy, Eva, Cocciardi, Sibylle, Seidens, Tatjana, McCart Reed, Amy E., Dalley, Andrew J., Wockner, Leesa F., Johnson, Julie, Sarkar, Debina, Askarian-Amiri, Marjan E., Simpson, Peter T., Khanna, Kum Kum, Chenevix-Trench, Georgia, Al-Ejeh, Fares and Lakhani, Sunil R. (2017). Multidimensional phenotyping of breast cancer cell lines to guide preclinical research. Breast Cancer Research and Treatment, 167 (1), 1-13. doi: 10.1007/s10549-017-4496-x

Multidimensional phenotyping of breast cancer cell lines to guide preclinical research

2017

Journal Article

Relationship of the breast ductal carcinoma in situ immune microenvironment with clinicopathological and genetic features

Hendry, Shona, Pang, Jia-Min B., Byrne, David J., Lakhani, Sunil R., Cummings, Margaret C., Campbell, Ian G., Mann, G. Bruce, Gorringe, Kylie L. and Fox, Stephen B. (2017). Relationship of the breast ductal carcinoma in situ immune microenvironment with clinicopathological and genetic features. Clinical Cancer Research, 23 (17), 5210-5217. doi: 10.1158/1078-0432.CCR-17-0743

Relationship of the breast ductal carcinoma in situ immune microenvironment with clinicopathological and genetic features

2017

Journal Article

Assessing tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the International Immunooncology Biomarkers Working Group: Part 1: assessing the host immune response, TILs in invasive breast carcinoma and ductal carcinoma in situ, metastatic tumor deposits and areas for further research

Hendry, Shona, Salgado, Roberto, Gevaert, Thomas, Russell, Prudence A., John, Tom, Thapa, Bibhusal, Christie, Michael, van de Vijver, Koen, Estrada, M. V, Gonzalez-Ericsson, Paula I, Sanders, Melinda, Solomon, Benjamin sss, Solinas, Cinzia, Van den Eynden, Gert G. G. M., Allory, Yves, Preusser, Matthias, Hainfellner, Johannes, Pruneri, Giancarlo, Vingiani, Andrea, Demaria, Sandra, Symmans, Fraser, Nuciforo, Paolo, Comerma, Laura, Thompson, E. A., Lakhani, Sunil, Kim, Seong-Rim, Schnitt, Stuart, Colpaert, Cecile, Sotiriou, Christos ... Fox, Stephen B. (2017). Assessing tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the International Immunooncology Biomarkers Working Group: Part 1: assessing the host immune response, TILs in invasive breast carcinoma and ductal carcinoma in situ, metastatic tumor deposits and areas for further research. Advances in Anatomic Pathology, 24 (5), 235-251. doi: 10.1097/PAP.0000000000000162

Assessing tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the International Immunooncology Biomarkers Working Group: Part 1: assessing the host immune response, TILs in invasive breast carcinoma and ductal carcinoma in situ, metastatic tumor deposits and areas for further research

2017

Journal Article

Erratum: DUB3 and USP7 de-ubiquitinating enzymes control replication inhibitor Geminin: molecular characterization and associations with breast cancer (Oncogene (2017) 36 33 (4802-4809))

Hernández-Pérez, S., Cabrera, E., Salido, E., Lim, M., Reid, L., Lakhani, S. R., Khanna, K. K., Saunus, J. M. and Freire, R. (2017). Erratum: DUB3 and USP7 de-ubiquitinating enzymes control replication inhibitor Geminin: molecular characterization and associations with breast cancer (Oncogene (2017) 36 33 (4802-4809)). Oncogene, 36 (33), 4817-4817. doi: 10.1038/onc.2017.220

Erratum: DUB3 and USP7 de-ubiquitinating enzymes control replication inhibitor Geminin: molecular characterization and associations with breast cancer (Oncogene (2017) 36 33 (4802-4809))

2017

Journal Article

Next-generation sequencing of endobronchial ultrasound transbronchial needle aspiration specimens in lung cancer

Fielding, David, Dalley, Andrew J., Bashirzadeh, Farzad, Singh, Mahendra, Nandakumar, Lakshmy, Reed, Amy E. McCart, Black, Debra, Kazakoff, Stephen, Nones, Katia, Pearson, John, Waddell, Nic, Lakhani, Sunil R. and Simpson, Peter T. (2017). Next-generation sequencing of endobronchial ultrasound transbronchial needle aspiration specimens in lung cancer. American Journal of Respiratory and Critical Care Medicine, 196 (3), 388-391. doi: 10.1164/rccm.201609-1935LE

Next-generation sequencing of endobronchial ultrasound transbronchial needle aspiration specimens in lung cancer

2017

Journal Article

Breast ductal carcinoma in situ carry mutational driver events representative of invasive breast cancer

Pang, Jia-Min B., Savas, Peter, Fellowes, Andrew P., Arnau, Gisela Mir, Kader, Tanjina, Vedururu, Ravikiran, Hewitt, Chelsee, Takano, Elena A., Byrne, David J., hoong, David Y. H., Millar, Ewan K. A., Lee, C. Soon, O'Toole, Sandra A., Lakhani, Sunil R., Cummings, Margaret C., Mann, G. Bruce, Campbell, Ian G., Dobrovic, Alexander, Loi, Sherene, Gorringe, Kylie L. and Fox, Stephen B. (2017). Breast ductal carcinoma in situ carry mutational driver events representative of invasive breast cancer. Modern Pathology, 30 (7), 952-963. doi: 10.1038/modpathol.2017.21

Breast ductal carcinoma in situ carry mutational driver events representative of invasive breast cancer

2017

Journal Article

HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures

Davies, Helen, Glodzik, Dominik, Morganella, Sandro, Yates, Lucy R., Staaf, Johan, Zou, Xueqing, Ramakrishna, Manasa, Martin, Sancha, Boyault, Sandrine, Sieuwerts, Anieta M., Simpson, Peter T., King, Tari A., Raine, Keiran, Eyfjord, Jorunn E., Kong, Gu, Borg, Åke, Birney, Ewan, Stunnenberg, Hendrik G., Van De Vijver, Marc J., Borresen-Dale, Anne-Lise, Martens, John W. M., Span, Paul N., Lakhani, Sunil R., Vincent-Salomon, Anne, Sotiriou, Christos, Tutt, Andrew, Thompson, Alastair M., Van Laere, Steven, Richardson, Andrea L. ... Nik-Zainal, Serena (2017). HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures. Nature Medicine, 23 (4), 517-525. doi: 10.1038/nm.4292

HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures

2017

Conference Publication

Investigating the HER2-3 dimer as a theranostic target in brain metastases

Saunus, J. M., Croft, P. K.-D., Lee, F. T., Al-Ejeh, F., Lim, M., Ensbey, K., Niland, C., Jeffree, R. L., Thomas, P., Day, B. W., Rose, S., Scott, A. M. and Lakhani, S. R. (2017). Investigating the HER2-3 dimer as a theranostic target in brain metastases. 16th Biennial Congress of the Metastasis Research Society, Chengdu, China, 16-20 September 2016. Dordrecht, Netherlands: Springer. doi: 10.1007/s10585-017-9843-0

Investigating the HER2-3 dimer as a theranostic target in brain metastases